These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 36819551)

  • 1. Development and validation of an inflammatory response-related prognostic model and immune infiltration analysis in glioblastoma.
    Zhu W; Luo N; Li Q; Chen X; Li X; Fu M; Yang F; Chen Z; Zhang Y; Zhang Y; Peng X; Hu G
    Ann Transl Med; 2023 Jan; 11(2):69. PubMed ID: 36819551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses.
    Liu YQ; Wu F; Li JJ; Li YF; Liu X; Wang Z; Chai RC
    Front Oncol; 2019; 9():1433. PubMed ID: 31921684
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma.
    Xu S; Wang Z; Ye J; Mei S; Zhang J
    Front Oncol; 2021; 11():729103. PubMed ID: 34568059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
    Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
    Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme.
    Yu Z; Yang H; Song K; Fu P; Shen J; Xu M; Xu H
    Front Oncol; 2022; 12():938679. PubMed ID: 35982954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a glioma prognostic model based on telomere-related genes and immune infiltration analysis.
    Liu X; Wang J; Su D; Wang Q; Li M; Zuo Z; Han Q; Li X; Zhen F; Fan M; Chen T
    Transl Cancer Res; 2024 Jul; 13(7):3182-3199. PubMed ID: 39145097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of a novel robust glioblastoma prognosis model based on bioinformatics.
    Zhang L; Yan X; Wang Y; Wang Q; Yan H; Yan Y
    Heliyon; 2024 Sep; 10(18):e37374. PubMed ID: 39309926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma.
    Bi Y; Wu ZH; Cao F
    BMC Cancer; 2022 Mar; 22(1):233. PubMed ID: 35241019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and validation of an immune-based prognostic score model in glioblastoma.
    Qin Z; Zhang X; Chen Z; Liu N
    Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of neurotrophic factor-related gene signatures in glioblastoma and Parkinson's disease.
    Zhao S; Chi H; Yang Q; Chen S; Wu C; Lai G; Xu K; Su K; Luo H; Peng G; Xia Z; Cheng C; Lu P
    Front Immunol; 2023; 14():1090040. PubMed ID: 36825022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of oncostatin M receptor regulates local immune response in glioblastoma.
    Guo Q; Guan GF; Cao JY; Zou CY; Zhu C; Cheng W; Xu XY; Lin ZG; Cheng P; Wu AH
    J Cell Physiol; 2019 Sep; 234(9):15496-15509. PubMed ID: 30693511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and Validation of an Immune-Related Risk Score Model for Survival Prediction in Glioblastoma.
    Ren W; Jin W; Liang Z
    Front Neurol; 2022; 13():832944. PubMed ID: 35370869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Prognostic Microenvironment-Related Immune Signature
    Qiu H; Li Y; Cheng S; Li J; He C; Li J
    Front Oncol; 2020; 10():580263. PubMed ID: 33425732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new prognostic model for glioblastoma multiforme based on coagulation-related genes.
    Zhou M; Deng Y; Fu Y; Liang R; Liu Y; Liao Q
    Transl Cancer Res; 2023 Oct; 12(10):2898-2910. PubMed ID: 37969372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
    Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
    J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis.
    Zhang Z; Shen X; Tan Z; Mei Y; Lu T; Ji Y; Cheng S; Xu Y; Wang Z; Liu X; He W; Chen Z; Chen S; Lv Q
    Front Genet; 2022; 13():1053263. PubMed ID: 36712869
    [No Abstract]   [Full Text] [Related]  

  • 17. Development and validation of an immune infiltration/tumor proliferation-related Notch3 nomogram for predicting survival in patients with primary glioblastoma.
    Zheng ZQ; Zhang GG; Yuan GQ; Hao JH; Nie QQ; Zheng MC; Wang Z
    Front Genet; 2023; 14():1148126. PubMed ID: 37284062
    [No Abstract]   [Full Text] [Related]  

  • 18. Pyroptosis-related prognosis model, immunocyte infiltration characterization, and competing endogenous RNA network of glioblastoma.
    Ding MR; Qu YJ; Peng X; Chen JF; Zhang MX; Zhang T; Hu B; An HM
    BMC Cancer; 2022 Jun; 22(1):611. PubMed ID: 35658846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
    Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
    Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of oxidative stress-related lncRNA signatures in glioma reveals the discrepancy of prognostic and immune infiltration.
    Shi Z; Wu Y; Zhuo Q; Zuo Y; Lin J; Shi H; Zhou H; Xu Z
    Sci Rep; 2023 May; 13(1):7731. PubMed ID: 37173373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.